Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Immunology 2012
Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
Sanofi sees US FDA ruling for MS drug Lemtrada in Q4
Parent-of-origin effect in multiple sclerosis: observations in half-siblings.
Bullous pemphigoid in a patient with multiple sclerosis being treated with human immunoglobulin.
Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants.
Pharmacokinetics of fingolimod (FTY720) and a combined oral contraceptive coadministered in healthy women: drug-drug interaction study results.
Celiac disease and multiple sclerosis in the northwest of Iran.
Pharmaceutical approval update.
Multiple sclerosis: Risk of comorbid inflammatory diseases in MS might not be genetically determined.
Normal outcome of pregnancy with ongoing treatment with natalizumab.
Inhibition of Neuronal Degenerin/Epithelial Na+ Channels by the Multiple Sclerosis Drug 4-Aminopyridine.
Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
Comprehending the inexplicable: qualitative accounts of black Caribbean and white british people severely affected by multiple sclerosis.
Materials for stem cell factories of the future.
Positive year one results from Biogen Idec's Phase 3 advance trial of PLEGRIDY™ (peginterferon beta-1a) presented at AAN meeting
Receptos provides update on progress of lead product candidate RPC1063
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
Genmab collaborator GSK starts new ofatumumab Phase III study in rare skin disorder
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.
A genome screen for multiple sclerosis in Italian families.
Epstein-Barr virus: an important vaccine target for cancer prevention.
An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients.
Targeting insulin-like growth factor 1 leads to amelioration of inflammatory demyelinating disease.
The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.

Pages